Document:

Exhibit 4.3

<PAGE>

                                  BUNGE LIMITED
                             NON-EMPLOYEE DIRECTORS
                              EQUITY INCENTIVE PLAN

                  Bunge Limited, a company organized under the laws of Bermuda
("Bunge"), hereby establishes an equity compensation plan to be known as the
Bunge Limited Non-Employee Directors Equity Incentive Plan (the "Plan"). The
Plan shall become effective as of the Effective Date, as defined in Section 9
below. Capitalized terms that are not otherwise defined in the text of this Plan
are defined in Section 2 below.

1.       Purpose

                  The purpose of the Plan is to promote the long-term growth and
financial success of Bunge and its Subsidiaries by attracting, motivating and
retaining non-employee directors of outstanding ability and assisting the
Company in promoting a greater identity of interest between the Company's
non-employee directors and its stockholders.

2.       Definitions

                  For purposes of the Plan, the following terms shall be defined
as follows:

                  "Annual Meeting" means an annual meeting of the Company's
         stockholders.

                  "Board" means the Board of Directors of the Company.

                  "Change in Control" shall have the meaning set forth in the
         Bunge Limited Equity Incentive Plan as in effect from time to time, or
         any successor thereto.

                  "Common Stock" means shares in the capital of Bunge, including
         ordinary shares and non-voting shares.

                  "Company" means Bunge Limited, a corporation organized under
         the laws of Bermuda, or any successor to substantially all its
         business.

                  "Director Option" means a right to purchase Shares of Common
         Stock granted to a Non-Employee Director pursuant to Section 6 below.

                  "Effective Date" means the effective date of the Plan provided
         for in Section 9 below.

                  "Fair Market Value" of a Share of Common Stock as of any date
         means:

                           (i) if the Common Stock is listed on an
                  established stock exchange or exchanges (including for
                  this purpose, the NASDAQ National Market), the average of
                  the highest and lowest sale prices of the stock quoted
                  for such date as reported in the Transactions Index of
                  each such exchange, as published in The Wall Street
                  Journal and determined by the Board, or, if no sale price
                  was quoted
<PAGE>

                  in any such Index for such date, then as of the next preceding
                  date on which such a sale price was quoted;

                           (ii) if the Common Stock is not then listed on
                  an exchange or the NASDAQ National Market, the average of
                  the closing bid and asked prices per Share for the stock
                  in the over-the-counter market as quoted on The NASDAQ
                  Small Cap or OTC Electronic Bulletin Board, as
                  appropriate, on such date; or

                           (iii) if the Common Stock is not then listed on
                  an exchange or quoted in the over-the-counter market, an
                  amount determined in good faith by the Board; provided,
                  however, that, when appropriate, the Board, in
                  determining Fair Market Value of the Common Stock, may
                  take into account such factors as it may deem appropriate
                  under the circumstances.

                  "Non-Employee Director" means a member of the Board who
         is not an employee of the Company or any of its Subsidiaries.

                  "Permanent Disability" means a physical or mental
         impairment rendering a Non-Employee Director substantially unable
         to function as a member of the Board for any period of six
         consecutive months. Any dispute as to whether a Non-Employee
         Director is Permanently Disabled shall be resolved by a physician
         mutually acceptable to the Non-Employee Director and the Company,
         whose decision shall be final and binding upon the Non-Employee
         Director and the Company.

                  "Person" means any individual, firm, corporation,
         partnership or other entity.

                  "Retirement" shall mean retirement from the Board in
         accordance with the retirement policy then in effect for Board
         members.

                  "Shares" means shares comprising the Common Stock.

                  "Subsidiary" means (i) a corporation or other entity with
         respect to which Bunge, directly or indirectly, has the power,
         whether through the ownership of voting securities, by contract or
         otherwise, to elect at least a majority of the members of such
         corporation's board of directors or analogous governing body, or
         (ii) any other corporation or other entity in which Bunge,
         directly or indirectly, has an equity or similar interest and
         which the Board designates as a Subsidiary for purposes of the
         Plan.

                                     2
<PAGE>

3.       Administration

                  (a) Administration by the Board. The Plan shall be
administered by the Board, which may adopt rules and regulations it considers
necessary or appropriate to carry out the Plan's purposes. The Board's
interpretation and construction of any Plan provision shall be final and
conclusive. The Board may, but need not, from time to time delegate some or all
of its authority under the Plan to a committee consisting of one or more members
of the Board, any such delegation to be subject to the restrictions and limits
that the Board specifies at the time of such delegation or thereafter.
References in the Plan to the "Board" shall, to the extent consistent with the
terms and limitations of any such delegation, be deemed to include a reference
to any such committee to which the Board's authority hereunder has been
delegated.

                  (b) Award Certificate. The terms and conditions of each grant
of Director Options under the Plan shall be embodied in an award agreement or
award certificate which shall incorporate the Plan by reference and shall
indicate the date on which the Director Options were granted and the number of
Director Options granted on such date.

4.       Shares Available

                  (a) General. Subject to adjustment as provided in Section 11
hereof, the number of Shares of Common Stock that may be issued pursuant to the
exercise of Director Options under the Plan (the "Section 4 Limit") shall not
exceed, in the aggregate, 0.5 percent (or one-half of one percent) of the issued
Shares of Common Stock outstanding.

                  (b) Rules Applicable to Determining Shares Available for
Issuance. For purposes of determining the number of Shares of Common Stock that
remain available for issuance, the following Shares shall be added back to the
Section 4 Limit and again be available for awards:

                  (i) The number of Shares tendered to pay the exercise price of
         a Director Option;

                  (ii) The number of Shares withheld from the exercise of any
         Director Option to satisfy a Non-Employee Director's tax withholding
         obligations or, if applicable, to pay the exercise price of a Director
         Option; and

                  (iii) The number of Shares subject to Director Options that
         expire unexercised or that become forfeited.

                  Either authorized and unissued Shares of Common Stock or
treasury Shares may be delivered pursuant to the Plan.

5.       Eligibility

                  Director Options shall be granted only to Non-Employee
Directors.

                                     3
<PAGE>

6.       Grants of Director Options

                  (a) General. A Director Option shall entitle a Non-Employee
Director to purchase a specified number of Shares of Common Stock during a
specified period at an exercise price per Share of Common Stock determined as
provided below. All Director Options provided for herein shall have the general
terms and conditions set forth in Section 7 below. Director Options shall be
nonqualified stock options and are not intended to qualify as "incentive stock
options" under Section 422 of the US Internal Revenue Code of 1986, as amended.

                  (b) Annual Grants of Director Options. As of the date of each
Annual Meeting, commencing with the 2001 Annual Meeting, each Non-Employee
Director shall automatically receive Director Options to purchase 7,200 Shares
of Common Stock provided that the Non-Employee Director shall continue to serve
as a director of the Company after such Annual Meeting. The exercise price per
Share of Common Stock subject to each Director Option provided for in this
Section 6(b) shall be the Fair Market Value of one Share of Common Stock on the
date of the relevant Annual Meeting.

                  (c) Grants of Director Options to New Directors. In addition
to the annual grants described in Section 6(b) above, a Non-Employee Director
who is initially elected or appointed to the Board, whether or not such election
or appointment is in connection with an Annual Meeting, shall receive, as of the
date of such initial election or appointment, Director Options to purchase 9,000
Shares of Common Stock. The exercise price per Share of Common Stock of each
Director Option provided for in this Section 6(c) shall be the Fair Market Value
of one Share of Common Stock on the date of the Non-Employee Director's election
or appointment to the Board.

                  (d) Grants to Non-Employee Directors as of the 2001 Annual
Meeting. All Non-Employee Directors serving on the Board at the time of the 2001
Annual Meeting shall receive both the initial grant described in Section 6(c)
above and the annual grant described in Section 6(b) above.

7.       General Terms and Conditions of Director Options

                  (a) Option Term. Each Director Option shall expire on the date
of the Annual Meeting held in the tenth calendar year following the date of
grant, subject to earlier expiration as provided herein; provided, however, that
Director Options granted to a Non-Employee Director whose initial election
occurs other than in connection with an Annual Meeting shall be treated for this
purpose as though they had been granted at the first Annual Meeting following
such initial election.

                  (b) Vesting; Accelerated Vesting; Effect of Termination of
Service.

                  (i) Vesting Generally. Director Options shall vest and become
         exercisable as of the first anniversary of the date of grant, assuming
         that the Non-Employee Director has continued to serve as a member of
         the Board until such first anniversary. Notwithstanding the preceding
         sentence, all Director Options shall be considered fully vested and
         exercisable upon the termination of the Non-Employee Director's service
         on the Board by reason of Retirement, death, Permanent Disability or by
         reason of failure by

                                     4
<PAGE>

         the stockholders to reelect such Non-Employee Director. Any Director
         Options that are unvested at the time of a termination of a
         Non-Employee Director's service on the Board shall lapse and become
         void.

                  (ii) Exercise Following Termination of Service. Following
         termination of a Non-Employee Director's service on the Board, the
         former Non-Employee Director (or the former Non-Employee Director's
         estate, personal representative or beneficiary, as the case may be)
         shall have the right, subject to the other terms and conditions hereof,
         to exercise all Director Options that had vested as of or in connection
         with the termination of service:

                           (A) at any time within three years after the
                  date of termination of service, if such termination was
                  by reason of Retirement, death, Permanent Disability or
                  by reason of failure by the stockholders to reelect such
                  Non-Employee Director, or

                           (B) in all other cases,  at any time within one year
                  after the date of  termination of service;

         subject, in all cases, to earlier expiration of the Director Option
         pursuant to Section 7(a) above.

                  (c) Notice of Exercise. Subject to the other terms and
conditions of the Plan, a Non-Employee Director may exercise all or any portion
of a vested Director Option by giving notice of exercise to the Company or its
designated agent; provided, however, that no fewer than one hundred (100) Shares
of Common Stock may be purchased upon any exercise of a Director Option unless
the number of Shares purchased at such time is the total number of Shares in
respect of which the Director Option is then exercisable, and provided further,
that in no event shall the Option be exercisable for a fractional Share. The
date of exercise of an Option shall be the later of (i) the date on which the
Company or its agent receives such notice or (ii) the date on which the
conditions provided in Sections 7(d) and 7(e) below are satisfied.

                  (d) Payment. The exercise price of a Director Option may be
paid in cash or previously owned Shares or a combination thereof or by any other
method approved by the Board.

                  (e) Limitation on Exercise. A Director Option shall not be
exercisable unless the Common Stock subject thereto has been registered under
the Securities Act of 1933, as amended (the "1933 Act"), and qualified under
applicable state "blue sky" laws in connection with the offer and sale thereof,
or the Company has determined that an exemption from registration under the 1933
Act and from qualification under such state "blue sky" laws is available.

                  (f) Issuance of Shares. Subject to the foregoing conditions,
as soon as is reasonably practicable after its receipt of a proper notice of
exercise and payment of the exercise price for the number of Shares with respect
to which a Director Option is exercised, the Company shall deliver to the
exercising Non-Employee Director, at the principal office of the Company or at
such other location as may be acceptable to the Company and the Non-Employee

                                     5
<PAGE>

Director, one or more stock certificates for the appropriate number of Shares of
Common Stock issued in connection with such exercise. Such Shares shall be fully
paid and nonassessable and shall be issued in the name of the Non-Employee
Director. Notwithstanding the foregoing, the Board in its discretion may,
subject to rules and procedures as it may adopt from time to time, provide
Non-Employee Directors with the opportunity to defer receipt of Shares of Common
Stock issuable upon exercise of Director Options.

8.       Transferability

                  Director Options may not be transferred, pledged, assigned or
otherwise disposed of except by will or the laws of descent and distribution or
pursuant to a domestic relations order; provided, however, that the Board may,
in its discretion and subject to such terms and conditions as it shall specify,
permit the transfer of a Director Option for no consideration to a Non-Employee
Director's family members or to one or more trusts or partnerships established
in whole or in part for the benefit of one or more of such family members
(collectively, "Permitted Transferees"). Any Director Option transferred to a
Permitted Transferee shall be further transferable only by will or the laws of
descent and distribution or, for no consideration, to another Permitted
Transferee of the Non-Employee Director. A Non-Employee Director shall notify
the Company in writing prior to any proposed transfer of a Director Option to a
Permitted Transferee and shall furnish the Company, upon request, with
information concerning such Permitted Transferee's financial condition and
investment experience.

9.       Term

                  The "Effective Date" shall be May 25, 2001. Unless earlier
terminated in accordance with Section 10 below, the Plan shall expire on the
tenth anniversary of the Effective Date (the "Expiration Date"). No Director
Options shall be granted under the Plan after the Expiration Date. However, the
expiration of the Plan shall not affect awards of Director Options made on or
prior to the Expiration Date, which awards shall remain outstanding subject to
the terms hereof.

10.      Amendments

                  The Board may at any time and from time to time alter, amend,
suspend or terminate the Plan in whole of in part, including without limitation
to amend the provisions for determining the amount of Director Options to be
issued to a Non-Employee Director; provided, however, that any amendment which
under the requirements of applicable law or stock exchange rule must be approved
by the stockholders of the Company shall not be effective unless and until such
stockholder approval has been obtained in compliance with such law or rule.

No termination or amendment of the Plan that would adversely affect a
Non-Employee Director's rights under the Plan with respect to any award of
Director Options made prior to such action shall be effective as to such
Non-Employee Director unless he or she consents thereto.

11.      Recapitalization or Reorganization

                  (a) Authority of the Company and Stockholders. The existence
of the Plan or awards hereunder shall not affect or restrict in any way the
right or power of the Company or the

                                     6
<PAGE>

stockholders of the Company to make or authorize any adjustment,
recapitalization, reorganization or other change in the Company's capital
structure or its business, any merger or consolidation of the Company, any issue
of stock or of options, warrants or rights to purchase stock or of bonds,
debentures, preferred or prior preference stocks whose rights are superior to or
affect the Common Stock or the rights thereof or which are convertible into or
exchangeable for Common Stock, or the dissolution or liquidation of the Company,
or any sale or transfer of all or any part of its assets or business, or any
other corporate act or proceeding, whether of a similar character or otherwise.

                  (b) Change in Control. In addition to the alternatives
described in Section 11(c) below, in the event of a Change in Control, the Board
in its sole discretion may take such measures as it deems appropriate with
respect to any outstanding Director Options, which measures may include, without
limitation, the acceleration of vesting, the rollover of outstanding Director
Options into awards exercisable for or subject to the acquirer's securities, the
cash out of vested Director Options or any combination of the forgoing;
provided, however, that unless the Board, in its sole discretion, determines
otherwise, in the event of a Change in Control all outstanding Director Options
shall become fully vested immediately prior to the consummation of such Change
in Control transaction.

                  (c) Change in Capitalization. The number and kind of Shares
authorized for issuance under Section 4(a) above shall be equitably adjusted in
the event of a stock split, stock dividend, recapitalization, reorganization,
merger, consolidation, extraordinary dividend, split-up, spin-off, combination,
exchange of shares, warrants or rights offering to purchase Common Stock at a
price substantially below Fair Market Value, or other similar corporate event
affecting the Common Stock in order to preserve, but not increase, the benefits
or potential benefits intended to be made available under the Plan. In addition,
upon the occurrence of any of the foregoing events, the number of outstanding
Director Options and the number and kind of Shares subject to any outstanding
Director Options and the exercise price per Share shall be equitably adjusted in
order to preserve the benefits or potential benefits intended to be made
available to Non-Employee Directors granted Director Options. Such adjustments
shall be made by the Board, whose determination as to what adjustments shall be
made, and the extent thereof, shall be final. Unless otherwise determined by the
Board, such adjusted Director Options shall be subject to the same vesting
schedule and restrictions to which the underlying Director Option is subject.

                                     7
<PAGE>

12.      No Right to Re-election

                  Nothing in the Plan shall be deemed to create any obligation
on the part of the Board to nominate any of its members for re-election by the
Company's stockholders, nor confer upon any Non-Employee Director the right to
remain a member of the Board for any period of time, or at any particular rate
of compensation.

13.      Governing Law

                  The Plan and all agreements entered into under the Plan shall
be construed in accordance with and governed by the laws of the State of New
York.

14.      Unfunded Plan

                  The Plan is unfunded. Prior to the exercise of any Director
Options, nothing contained herein shall give any Non-Employee Director any
rights that are greater than those of a general creditor of the Company. In its
sole discretion, the Board may authorize the creation of trusts or other
arrangements to meet the obligations created under the Plan to deliver Common
Stock with respect to awards hereunder.

15.      Compliance with Rule 16b-3

                  Notwithstanding anything contained in the Plan to the
contrary, if the consummation of any transaction under the Plan would result in
the possible imposition of liability on a Non-Employee Director pursuant to
Section 16(b) of the Securities Exchange Act of 1934, as amended, the Board
shall have the right, in its sole discretion, but shall not be obligated, to
defer such transaction or the effectiveness of such action to the extent
necessary to avoid such liability, but in no event for a period longer than six
months.

16.      Stated Periods of Time

                  In the event that any period of days, months or years set
forth in this Plan ends on a date that is Saturday, Sunday or a public holiday
in the United States, the end of such period shall be the first business day
following such date.

                  The Plan was adopted by the Board on September 28, 2001.

                                     8<PAGE>
                                                                    Exhibit 10.1

November 6, 2001

Vitaquest International, Inc.
8 Henderson Drive
West Caldwell, New Jersey 07006

Attn: Keith Frankel, President/CEO

      Re: Proposed Transactions between Infotopia, Inc. and Vitaquest
          International, Inc.

Dear Mr. Frankel:

            This Letter of Intent sets forth the terms regarding the proposed
transactions (the "Transactions") between Infotopia, Inc., a Nevada corporation
("Infotopia") and Vitaquest International, Inc., a Delaware corporation
("Vitaquest"). This letter must be accepted by Vitaquest on or before the close
of business on November 6, 2001 (New York time), to constitute a binding
agreement in accordance with the terms provided herein.

      1. Background.

            A. Danmark Inc. d/b/a DMI and Beacon Marketing Services
(collectively, "DMI") have filed petitions for relief under Chapter 11 of the
United States Bankruptcy Code (the "Code") with the United States Bankruptcy
Court for the District of Maine (the "Court") on September 7, 2001, which
commenced the proceedings styled In re Danmark, Inc., Bankr. No. 01-21420 and In
re Beacon Marketing Services, Inc., Bankr. No. 01-21421 (together, the
"Bankruptcy Proceedings").

            B. Vitaquest is a secured creditor of DMI in the aggregate principal
amount of $ ______________ plus ______________ or a total of $ ________________
(the "Debt"). Payment of the Debt is secured by a prior security interest on
DMI's assets set forth on Schedule "A" annexed hereto, as such schedule shall be
amended and modified up to the close of business on November 8, 2001 (the
"Assets"). Vitaquest is in the process of pursuing and obtaining a final
non-appealable order in the Bankruptcy Proceedings (the "Order") pursuant to
which Vitaquest will acquire substantially all of the Assets pursuant to a bid,
as a secured creditor, pursuant to Section 363(k)of the Code in a section 363
bankruptcy sale (the "Sale").

            C. Vitaquest wishes to assign, and Infotopia wishes to purchase,
title to the Assets or at Infotopia's option, Vitaquest's rights under the
Order. If the Sale shall occur, Vitaquest will provide to Infotopia a copy of
the proposed Order prior to the Sale. Vitaquest agrees to seek to include in the
Order any provisions which Infotopia shall reasonably request, provided such
request does not adversely impact Vitaquest, the enforceability of the Order or
Vitaquest's interests in the Assets.

      2. Assignment of Rights Under Order/Assets. Subject to the terms and
conditions set forth below, Vitaquest shall assign and transfer to Infotopia (i)
the Assets (excluding the "Chitosol" brand and such related assets, including
but not limited to, the Chitosol infomercial) or (ii) at Infotopia's request,
Vitaquest's rights to acquire the Assets (excluding the "Chitosol" brand and
such related assets, including but not limited to, the Chitosol infomercial)
pursuant to the Order (the "Rights"). In exchange for the purchase of the Assets
or the assignment of the Rights (excluding, in either case, the "Chitosol" brand
and such related assets, including but not limited to, the Chitosol infomercial,
which such "Chitosol" brand and such related assets shall be licensed by
Vitaquest to Infotopia at the Closing until such time as the Total Consideration
shall have been paid in full, at which time Vitaquest shall assign the
"Chitosol" brand and such related assets to Infotopia), as applicable, Infotopia
shall provide to Vitaquest the following consideration:

                                       1
<PAGE>
            Total Consideration to Vitaquest: Four Million Eight Hundred
            Thousand Dollars, without interest, ($4,800,000.00) ("Total
            Consideration") payable in accordance with the following schedule:

            $500,000 upon closing of the assignment of the Assets or the Rights
            (the "Closing");
            $500,000 within 30 days following the Closing;
            $1,000,000 within 60 days following the Closing; and
            $500,000 at the end of each 30-day period thereafter until the Total
            Consideration shall have been provided to Vitaquest, the final
            payment being in the amount of the unpaid portion of the Total
            Consideration.

            To evidence Infotopia's obligations to Vitaquest, at the Closing,
Infotopia shall execute a promissory note payable to Vitaquest's order for the
balance of the Total Consideration outstanding ($4,300,000.00), such promissory
note shall be secured by a first priority security interest upon the Assets and
in all other assets of Infotopia, tangible and intangible. In order to
accomplish the foregoing, Infotopia shall also provide to Vitaquest such
security agreements, UCC-1 financing statements, UCC, tax, judgment and other
searches, opinion letters, corporate authorizations, and other documentation as
Vitaquest may reasonably request and Infotopia's counsel shall reasonably
approve.

            At the Closing, Infotopia shall assign to Vitaquest for a period
terminating upon Vitaquest's receipt of payment in full of the Total
Consideration, the rights to payment described below and shall contact the
necessary third parties of such effect, which payments will be made directly to
Vitaquest instead of Infotopia; provided, however, that upon Vitaquest's receipt
of the payment in full of the Total Consideration, Vitaquest shall re-assign the
remaining payments to Infotopia, if any. Until the re-assignment becomes
effective, all payments with respect thereto received by Vitaquest shall be held
in trust for, and remitted to, Infotopia:

               (a)   Any payments in connection with In re Premier Membership
                     Services, LLC., Bankr. No. 00-35053 U.S. Bankruptcy
                     Court, Southern District of Florida;  and

               (b)   Any payments or money returned by any credit card
                     processors, including but not limited to, Electronic Pay
                     Exchange and Merrick Bank (collectively "EPX") and
                     PaySystems.com, on account of any excess holdback reserves
                     or escrow in connection with DMI.

Any such payments received and retained by Vitaquest shall be credited against
the Total Consideration (such credits to be applied against payments due in the
inverse order of maturity).

            In addition, (i) any royalty payments due from Vitaquest to DMI
under a certain Exclusive License Agreement dated November 20, 2000 related
solely to sales by Vitaquest following the Closing, if any, shall be credited
against any remaining unpaid portion of the Total Consideration (such offset to
be applied against payments due in the inverse order of maturity).

            In the event of any defaults under the promissory note or
corresponding security agreements (and/or any other related documents) and after
30-days' written notice to Infotopia and opportunity to cure, if not cured
within such period, the license to use the "Chitosol" brand and all assets
related to such "Chitosol" brand shall terminate and Vitaquest shall be entitled
to enforce its rights and remedies under the promissory note, the security
agreements (and any other related documents), and retain all consideration paid
to date subject to Infotopia's rights as a debtor under the Uniform Commercial
Code.

                                       2
<PAGE>
      3. Effect of Appeal or Inability to Obtain Order and Bidding.

            A. Vitaquest agrees, at the Sale, to bid up to the full amount of
the Debt pursuant to Section 363(k) of the Code.

            B. If Vitaquest obtains the Order, but the Order is appealed, but
not stayed, then Vitaquest shall, in its sole discretion exercised in good
faith, have the right, but not the obligation, to proceed to Closing
notwithstanding such appeal pursuant to section 363(m) of the Code. If Vitaquest
elects not to proceed to Closing both parties' obligations shall terminate, and
this Letter of Intent shall be void ab initio (other than Infotopia's
obligations of confidentiality set forth in paragraph 5 and each parties'
obligations of non-publicity and confidentiality set forth in paragraph 11).

            C. If Vitaquest shall not obtain the Order by December 1, 2001,
Vitaquest shall move for relief from the automatic stay pursuant to section
362(d) of the Code. Thereafter, it shall seek to obtain possession of the Assets
under applicable law and realize thereon as a secured creditor by selling same
to Infotopia on the terms set forth relative to a Sale pursuant to the Order.

            D. If, in exercise of reasonable good faith, Vitaquest shall be
unable to obtain the Order, or shall be otherwise unable to obtain possession
and control of the Assets by March 31, 2002, this Letter of Intent shall be void
ab initio (other than Infotopia's obligations of confidentiality set forth in
paragraph 5 and each party's obligations of non-publicity and confidentiality
set forth in paragraph 11).

      4. Manufacturing Agreement. The parties shall negotiate a manufacturing
agreement regarding the sale by Vitaquest to Infotopia of dietary supplement
products. Such manufacturing agreement shall provide, among other things, for
payment in full to Vitaquest prior to shipment for any and all product purchased
from Vitaquest prior to shipment thereof.

      5. Due Diligence. In order to facilitate the due diligence review by
Infotopia, Vitaquest shall attempt to arrange with DMI to grant to Infotopia,
and its respective representatives, access during business hours to all of DMI's
respective books and records with respect to the business, finances and
operations of DMI and will attempt to provide facilities for Infotopia to make
copies of any of the Information as it deems necessary desirable. Infotopia and
its representatives shall conduct their due diligence review in such a manner so
as not to interfere unduly with the operation of DMI's business. In connection
with such review, Infotopia and its representatives shall, with DMI's prior
consent, be permitted to contact and communicate with customers, employees,
suppliers and others whose business directly related to DMI and its operations.
Infotopia shall be required to execute a standard Confidentiality Agreement in
connection with its review. Infotopia agrees that it will (a) use all
information obtained in its due diligence review solely for the purpose of
evaluating the Transactions, (b) will hold such information in confidence, and
(c) will not disclose such information except to its employees, agents,
representatives and professionals involved in the Transactions, which persons
shall be advised by Infotopia of the foregoing obligations. Unless otherwise
agreed by Vitaquest in writing, Infotopia shall complete its due diligence
review by November 9th, 2001. Vitaquest shall use reasonable good faith efforts
to obtain the Order and/or the Assets. Notwithstanding the foregoing or anything
herein or in any other document to the contrary, Vitaquest makes no
representations or warranties regarding the Assets or the Order nor does
Vitaquest make any representations or warranties that it will obtain such Assets
or Order.

      6. "No Shop" Clause. Prior to November 16, 2001 (or alternatively, if the
parties execute the Transaction Documents prior to November 16, 2001), Vitaquest
shall, (a) not make any disposition(s), pledge or hypothecation of the Assets or
the Rights, (b) enter into any agreement to do so or its interests therein and
(c) use commercially reasonable good faith efforts to obtain promptly any
consents or approvals required in connection with the Transactions.

                                       3
<PAGE>
      7. Management. Vitaquest shall be entitled to appoint one member to the
board of directors of Infotopia. Alternatively, Mr. Keith Frankel, at his
option, may serve as an advisor to the board of directors of Infotopia and may
participate in any meetings held by the board of directors.

      8. Conditions.

            A. Infotopia. The obligation of Infotopia to consummate the
Transactions is subject to the following conditions:

            (1) A due diligence period for review of all legal and financial
            documents relating to DMI and its operations which, unless otherwise
            agreed in writing, shall expire at the end of business of November
            9, 2001 (New York time).

      9. Transaction Documents. As soon as reasonably practicable after
Vitaquest's execution of this Letter of Intent, each of Infotopia and Vitaquest
shall use its reasonable commercial efforts to execute and deliver more detailed
agreements reflecting the terms set forth in this Letter of Intent
(collectively, the "Transaction Documents").

      10. Termination. This Letter of Intent may be terminated and shall be
deemed void ab initio, (a) at any time by the mutual written agreement of
Infotopia and Vitaquest, and (b) at any time by a party hereto if the other
party hereto shall have materially breached any of its obligations or agreements
hereunder, and fails to cure such breach within 10 days after written notice
thereto, or (c) pursuant to the terms hereof.

      11. Non-publicity and Confidentiality. Each of Infotopia and Vitaquest
agrees not to disclose the existence or contents of this letter agreement or the
Transactions without the prior written consent of the other party hereto, except
to its advisors and attorneys who or which have a need to know such information
and except as required by law.

      12. Expenses; Brokers and Finders. Infotopia and Vitaquest shall each bear
their respective costs and expenses incurred in connection with the negotiation,
preparation and consummation of the Transactions. Each of the parties represents
that it has not engaged any broker or finder in connection with the Transactions
and agrees to indemnify and hold harmless the other party in connection
therewith.

      13. Binding Nature; Covenant to Close. This Letter of Intent constitutes a
binding agreement between the parties hereto upon its execution. Each party
covenants to the other to use its commercially reasonable efforts to effect the
Transactions contemplated pursuant to this Letter of Intent and to satisfy the
conditions to closing the Transactions; provided, however, that if the Closing
shall occur prior to Vitaquest's receipt of the Order or grant of

                                       4
<PAGE>
relief from the stay, then the documents executed shall be placed in escrow with
Bondy & Schloss LLP until the earlier of (a) Vitaquest's receipt of the Order or
grant of relief from the stay or (b) termination of this Letter of Intent
pursuant to paragraph 3(D).

      14. Non-assignability: Governing Law. No party hereto may assign any of
its rights, or delegate any of its duties, hereunder without the prior written
consent of the other party hereto. This Letter of Intent shall be governed by
the internal laws of the State of New York, and any suit or action arising in
connection herewith shall be exclusively brought in the Federal or State courts
located in New York County, New York.

      Please indicate your acceptance and approval of this letter agreement by
having it executed and dated where indicated below, and returning an executed
copy to me on or before the close of business on November 6, 2001 (New York
time).

                                          Very truly yours,

                                          Infotopia, Inc.

                                          By: /s/ Daniel Hoyng
                                             _______________________
                                          Name:  Daniel Hoyng
                                          Title: CEO

ACCEPTED AND AGREED TO:

Vitaquest International Inc.

By:   /s/ Keith Frankel
     ______________________
Name:     Keith Frankel
Title:    CEO

Dated: November 6, 2001

                                       5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00033-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00033-of-00352.parquet"}]]